Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
S-8Securities offered to employees pursuant to employee benefit plansAug 9, 1999View HTMLDownload DOCDownload PDFDownload XLS
424B4Form of prospectus disclosing information facts events covered in both forms 424B1 424B3Jul 26, 1999View HTMLDownload DOCDownload PDFDownload XLS
S-1/AAmended Registration statement for face-amount certificate companiesJul 22, 1999View HTMLDownload DOCDownload PDFDownload XLS
S-1/AAmended Registration statement for face-amount certificate companiesJul 21, 1999View HTMLDownload DOCDownload PDFDownload XLS
8-A12GRegistration of certain classes of securities 12(g) of the Securities Exchange ActJul 15, 1999View HTMLDownload DOCDownload PDFDownload XLS
S-1/AAmended Registration statement for face-amount certificate companiesJul 6, 1999View HTMLDownload DOCDownload PDFDownload XLS
S-1/AAmended Registration statement for face-amount certificate companiesJun 14, 1999View HTMLDownload DOCDownload PDFDownload XLS
S-1Registration statement for face-amount certificate companiesMay 4, 1999View HTMLDownload DOCDownload PDFDownload XLS

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information